STOCK TITAN

[Form 4] Alumis Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Alumis Inc. (ALMS) – Form 4 insider filing

Chief Development Officer Mark Christopher Bradley reported new equity incentives dated 07/29/2025:

  • 26,750 restricted stock units (RSUs) at $0 cost. Vesting: 25 % on 08/01/2026, then equal quarterly installments over the next 12 quarters.
  • 107,100 stock options with a $3.95 exercise price, expiring 07/28/2035. Vesting: 25 % on 07/29/2026, then equal monthly installments over 36 months.

Following the grant Bradley now directly owns 48,728 common shares and indirectly controls 40,052 shares through two 2023 GRAT trusts. No open-market purchases or sales occurred; cash outlay was $0, so there is no immediate impact on Alumis’s liquidity or earnings. The awards are routine retention tools that modestly increase potential dilution while further aligning executive and shareholder interests.

Alumis Inc. (ALMS) – Comunicazione interna Modulo 4

Il Chief Development Officer Mark Christopher Bradley ha segnalato nuovi incentivi azionari datati 29/07/2025:

  • 26.750 unità di azioni vincolate (RSU) a costo zero. Vesting: 25% il 01/08/2026, poi rate trimestrali uguali per i successivi 12 trimestri.
  • 107.100 opzioni su azioni con prezzo di esercizio di 3,95 $, scadenza 28/07/2035. Vesting: 25% il 29/07/2026, poi rate mensili uguali per 36 mesi.

Dopo l’assegnazione, Bradley possiede direttamente 48.728 azioni ordinarie e controlla indirettamente 40.052 azioni tramite due trust GRAT del 2023. Non sono avvenuti acquisti o vendite sul mercato aperto; la spesa in contanti è stata pari a 0, quindi non c’è un impatto immediato sulla liquidità o sugli utili di Alumis. Questi premi sono strumenti di retention di routine che aumentano modestamente la potenziale diluizione, allineando ulteriormente gli interessi degli executive e degli azionisti.

Alumis Inc. (ALMS) – Presentación interna Formulario 4

El Director de Desarrollo, Mark Christopher Bradley, informó sobre nuevos incentivos de capital con fecha 29/07/2025:

  • 26,750 unidades de acciones restringidas (RSUs) sin costo. Consolidación: 25 % el 01/08/2026, luego cuotas trimestrales iguales durante los siguientes 12 trimestres.
  • 107,100 opciones sobre acciones con precio de ejercicio de $3.95, vencimiento 28/07/2035. Consolidación: 25 % el 29/07/2026, luego cuotas mensuales iguales durante 36 meses.

Tras la concesión, Bradley posee directamente 48,728 acciones ordinarias y controla indirectamente 40,052 acciones a través de dos fideicomisos GRAT de 2023. No hubo compras ni ventas en el mercado abierto; el desembolso en efectivo fue de $0, por lo que no hay impacto inmediato en la liquidez o ganancias de Alumis. Los premios son herramientas rutinarias de retención que aumentan modestamente la dilución potencial y alinean aún más los intereses de los ejecutivos y accionistas.

Alumis Inc. (ALMS) – 내부자 신고서 Form 4

최고개발책임자 Mark Christopher Bradley가 2025년 7월 29일자 신규 주식 인센티브를 보고했습니다:

  • 26,750 제한 주식 단위(RSU) 무상. 베스팅: 2026년 8월 1일 25%, 이후 다음 12분기 동안 동일 분기별 할부.
  • 107,100 주식 매수선택권 행사가격 $3.95, 만료일 2035년 7월 28일. 베스팅: 2026년 7월 29일 25%, 이후 36개월 동안 동일 월별 할부.

부여 후 Bradley는 직접적으로 48,728 보통주를 보유하고 있으며, 2023년 설정된 두 개의 GRAT 신탁을 통해 간접적으로 40,052주를 통제합니다. 공개 시장에서의 매매는 없었으며, 현금 지출은 0으로 Alumis의 유동성이나 수익에 즉각적인 영향은 없습니다. 이 보상은 경영진 유지용 일상적 도구로, 잠재적 희석을 다소 증가시키면서 경영진과 주주의 이해관계를 더욱 일치시킵니다.

Alumis Inc. (ALMS) – Déclaration d’initié Formulaire 4

Le Directeur du Développement, Mark Christopher Bradley, a déclaré de nouvelles incitations en actions datées du 29/07/2025 :

  • 26 750 unités d’actions restreintes (RSU) sans coût. Acquisition : 25 % au 01/08/2026, puis versements trimestriels égaux sur les 12 trimestres suivants.
  • 107 100 options d’achat d’actions à un prix d’exercice de 3,95 $, expirant le 28/07/2035. Acquisition : 25 % au 29/07/2026, puis versements mensuels égaux sur 36 mois.

Suite à cette attribution, Bradley détient désormais directement 48 728 actions ordinaires et contrôle indirectement 40 052 actions via deux trusts GRAT de 2023. Aucun achat ou vente sur le marché ouvert n’a eu lieu ; aucune dépense en espèces n’a été engagée, il n’y a donc pas d’impact immédiat sur la liquidité ou les résultats d’Alumis. Ces attributions sont des outils de rétention courants qui augmentent modestement la dilution potentielle tout en alignant davantage les intérêts des dirigeants et des actionnaires.

Alumis Inc. (ALMS) – Insider-Meldung Formular 4

Chief Development Officer Mark Christopher Bradley meldete neue Aktienanreize vom 29.07.2025:

  • 26.750 Restricted Stock Units (RSUs) ohne Kosten. Vesting: 25 % am 01.08.2026, danach gleiche vierteljährliche Raten über die nächsten 12 Quartale.
  • 107.100 Aktienoptionen mit einem Ausübungspreis von 3,95 $, Laufzeit bis 28.07.2035. Vesting: 25 % am 29.07.2026, danach gleiche monatliche Raten über 36 Monate.

Nach der Zuteilung besitzt Bradley nun direkt 48.728 Stammaktien und kontrolliert indirekt 40.052 Aktien über zwei 2023 eingerichtete GRAT-Trusts. Es gab keine Käufe oder Verkäufe am offenen Markt; der Barausgang betrug 0, somit gibt es keine unmittelbaren Auswirkungen auf die Liquidität oder das Ergebnis von Alumis. Die Zuteilungen sind routinemäßige Bindungsinstrumente, die die potenzielle Verwässerung geringfügig erhöhen und die Interessen von Führungskräften und Aktionären weiter angleichen.

Positive
  • Alignment of interests: 26,750 RSUs and 107,100 options link CDO compensation directly to future share performance.
Negative
  • Potential dilution: Option grant could add 107,100 shares to the float when exercised.

Insights

TL;DR: Routine retention grant; minimal dilution, stronger C-suite alignment, neutral near-term financial impact.

The 26.8k RSUs and 107.1k options constitute a standard post-IPO incentive package. At less than 1 % of outstanding shares, dilution risk is negligible. Front-loaded vesting and a 10-year option life encourage long-term value creation. Because neither cash changes hands today nor shares are sold, earnings, cash flow, and float remain essentially unchanged. Investors should view the filing as neutral, with a slight positive signal that leadership is incentivised to grow share price above the $3.95 strike.

TL;DR: Governance-friendly award structure; clear disclosure, aligns executive horizon with investors.

The grant follows the 2024 Equity Incentive Plan and features staggered vesting tied to continued service, limiting retention risk. Use of GRATs for indirect holdings is transparent and typical for estate planning. No Rule 10b5-1 sales were flagged. Overall, the filing supports a sound pay-for-performance framework without red-flag governance issues.

Alumis Inc. (ALMS) – Comunicazione interna Modulo 4

Il Chief Development Officer Mark Christopher Bradley ha segnalato nuovi incentivi azionari datati 29/07/2025:

  • 26.750 unità di azioni vincolate (RSU) a costo zero. Vesting: 25% il 01/08/2026, poi rate trimestrali uguali per i successivi 12 trimestri.
  • 107.100 opzioni su azioni con prezzo di esercizio di 3,95 $, scadenza 28/07/2035. Vesting: 25% il 29/07/2026, poi rate mensili uguali per 36 mesi.

Dopo l’assegnazione, Bradley possiede direttamente 48.728 azioni ordinarie e controlla indirettamente 40.052 azioni tramite due trust GRAT del 2023. Non sono avvenuti acquisti o vendite sul mercato aperto; la spesa in contanti è stata pari a 0, quindi non c’è un impatto immediato sulla liquidità o sugli utili di Alumis. Questi premi sono strumenti di retention di routine che aumentano modestamente la potenziale diluizione, allineando ulteriormente gli interessi degli executive e degli azionisti.

Alumis Inc. (ALMS) – Presentación interna Formulario 4

El Director de Desarrollo, Mark Christopher Bradley, informó sobre nuevos incentivos de capital con fecha 29/07/2025:

  • 26,750 unidades de acciones restringidas (RSUs) sin costo. Consolidación: 25 % el 01/08/2026, luego cuotas trimestrales iguales durante los siguientes 12 trimestres.
  • 107,100 opciones sobre acciones con precio de ejercicio de $3.95, vencimiento 28/07/2035. Consolidación: 25 % el 29/07/2026, luego cuotas mensuales iguales durante 36 meses.

Tras la concesión, Bradley posee directamente 48,728 acciones ordinarias y controla indirectamente 40,052 acciones a través de dos fideicomisos GRAT de 2023. No hubo compras ni ventas en el mercado abierto; el desembolso en efectivo fue de $0, por lo que no hay impacto inmediato en la liquidez o ganancias de Alumis. Los premios son herramientas rutinarias de retención que aumentan modestamente la dilución potencial y alinean aún más los intereses de los ejecutivos y accionistas.

Alumis Inc. (ALMS) – 내부자 신고서 Form 4

최고개발책임자 Mark Christopher Bradley가 2025년 7월 29일자 신규 주식 인센티브를 보고했습니다:

  • 26,750 제한 주식 단위(RSU) 무상. 베스팅: 2026년 8월 1일 25%, 이후 다음 12분기 동안 동일 분기별 할부.
  • 107,100 주식 매수선택권 행사가격 $3.95, 만료일 2035년 7월 28일. 베스팅: 2026년 7월 29일 25%, 이후 36개월 동안 동일 월별 할부.

부여 후 Bradley는 직접적으로 48,728 보통주를 보유하고 있으며, 2023년 설정된 두 개의 GRAT 신탁을 통해 간접적으로 40,052주를 통제합니다. 공개 시장에서의 매매는 없었으며, 현금 지출은 0으로 Alumis의 유동성이나 수익에 즉각적인 영향은 없습니다. 이 보상은 경영진 유지용 일상적 도구로, 잠재적 희석을 다소 증가시키면서 경영진과 주주의 이해관계를 더욱 일치시킵니다.

Alumis Inc. (ALMS) – Déclaration d’initié Formulaire 4

Le Directeur du Développement, Mark Christopher Bradley, a déclaré de nouvelles incitations en actions datées du 29/07/2025 :

  • 26 750 unités d’actions restreintes (RSU) sans coût. Acquisition : 25 % au 01/08/2026, puis versements trimestriels égaux sur les 12 trimestres suivants.
  • 107 100 options d’achat d’actions à un prix d’exercice de 3,95 $, expirant le 28/07/2035. Acquisition : 25 % au 29/07/2026, puis versements mensuels égaux sur 36 mois.

Suite à cette attribution, Bradley détient désormais directement 48 728 actions ordinaires et contrôle indirectement 40 052 actions via deux trusts GRAT de 2023. Aucun achat ou vente sur le marché ouvert n’a eu lieu ; aucune dépense en espèces n’a été engagée, il n’y a donc pas d’impact immédiat sur la liquidité ou les résultats d’Alumis. Ces attributions sont des outils de rétention courants qui augmentent modestement la dilution potentielle tout en alignant davantage les intérêts des dirigeants et des actionnaires.

Alumis Inc. (ALMS) – Insider-Meldung Formular 4

Chief Development Officer Mark Christopher Bradley meldete neue Aktienanreize vom 29.07.2025:

  • 26.750 Restricted Stock Units (RSUs) ohne Kosten. Vesting: 25 % am 01.08.2026, danach gleiche vierteljährliche Raten über die nächsten 12 Quartale.
  • 107.100 Aktienoptionen mit einem Ausübungspreis von 3,95 $, Laufzeit bis 28.07.2035. Vesting: 25 % am 29.07.2026, danach gleiche monatliche Raten über 36 Monate.

Nach der Zuteilung besitzt Bradley nun direkt 48.728 Stammaktien und kontrolliert indirekt 40.052 Aktien über zwei 2023 eingerichtete GRAT-Trusts. Es gab keine Käufe oder Verkäufe am offenen Markt; der Barausgang betrug 0, somit gibt es keine unmittelbaren Auswirkungen auf die Liquidität oder das Ergebnis von Alumis. Die Zuteilungen sind routinemäßige Bindungsinstrumente, die die potenzielle Verwässerung geringfügig erhöhen und die Interessen von Führungskräften und Aktionären weiter angleichen.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Richardson Derrick

(Last) (First) (Middle)
C/O ALUMIS INC.
280 EAST GRAND AVENUE

(Street)
SOUTH SAN FRANCISCO CA 94080

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
ALUMIS INC. [ ALMS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
SVP, People and Culture
3. Date of Earliest Transaction (Month/Day/Year)
07/29/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 07/29/2025 A 42,800(1) A $0 42,800 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy) $3.95 07/29/2025 A 64,200 (2) 07/28/2035 Common Stock 64,200 $0 64,200 D
Explanation of Responses:
1. Represents shares of common stock issuable upon settlement of a restricted stock unit ("RSU") grant. 25% of the shares underlying this RSU vest on August 1, 2026, and the remaining shares vest in equal quarterly installments thereafter over the following 12 quarters, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2024 Equity Incentive Plan) to the Issuer on each such vesting date.
2. 25% of the shares underlying this option vest on July 29, 2026, and the remaining shares vest in equal monthly installments thereafter over the following 36 months, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2024 Equity Incentive Plan) to the Issuer on each such vesting date.
/s/ Sanam Pangali, Attorney-in-Fact 07/31/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What equity awards did Alumis (ALMS) grant to its Chief Development Officer?

The company granted 26,750 RSUs and 107,100 stock options at a $3.95 exercise price.

When do the RSUs awarded on 07/29/2025 begin to vest?

25 % of the RSUs vest on 08/01/2026; the remainder vests quarterly over the next three years.

What is the expiration date of the new stock options?

The options expire on 07/28/2035.

How many Alumis shares does Mark Christopher Bradley now own?

He owns 48,728 shares directly and 40,052 shares indirectly through GRATs.

Did the insider sell any Alumis shares in this Form 4 filing?

No. The filing reports only awards; no sales or purchases of existing shares took place.

Will these awards impact Alumis’s financial statements immediately?

The grants involve no cash outlay; therefore, no immediate liquidity or earnings impact is expected, aside from standard non-cash compensation expense recognition.
Alumis Inc

NASDAQ:ALMS

ALMS Rankings

ALMS Latest News

ALMS Latest SEC Filings

ALMS Stock Data

426.17M
62.27M
0.83%
56.18%
3.13%
Biotechnology
Pharmaceutical Preparations
Link
United States
SOUTH SAN FRANCISCO